Investigational Site Number : 4840008

Veracruz 91910

1 studies enrolling now · 4 studies all time

What they study most

Asthma, Chronic Kidney Diseases, Heart Failure, Systemic Lupus Erythematosus, Type 2 Diabetes Mellitus

Studies at this site

• Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus — Running, not enrolling
• Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma — Enrolling by invitation
• Dose Ranging Study of Lunsekimig Compared With Placebo-control in Adult Participants With Moderate-to-severe Asthma — Completed
• Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk — Stopped early